Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hilton Worldwide
HLT
|
+$717M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$580M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$444M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$406M |
| 5 |
Walt Disney
DIS
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.27B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$1.05B |
| 4 |
Apple
AAPL
|
+$768M |
| 5 |
NVIDIA
NVDA
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.2% |
| 2 | Technology | 7.55% |
| 3 | Healthcare | 7.22% |
| 4 | Energy | 6.62% |
| 5 | Consumer Discretionary | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5726
CALL
Prothena Corp
PRTA
$448M
| $164K | ﹤0.01% |
4,700
-45,100
| -91% | -$1.96M |
|
|
WILN
5727
DELISTED
Wi-LAN Inc.
WILN
| $164K | ﹤0.01% |
64,591
-14,508
| -18% | -$36.5K |
|
|
AUO
5728
DELISTED
AU Optronics Corp
AUO
| $164K | ﹤0.01% |
46,855
-99,315
| -68% | -$281K |
|
5729
eHealth
EHTH
$41.9M
| $163K | ﹤0.01% |
+11,619
| New | +$141K |
|
|
FCSC
5730
DELISTED
Fibrocell Science Inc.
FCSC
| $163K | ﹤0.01% |
9,425
+7,269
| +337% | +$226K |
|
5731
Atlanticus Holdings
ATLC
$1.57B
| $162K | ﹤0.01% |
55,756
+16,129
| +41% | +$48.3K |
|
5732
CALL
Crown Holdings
CCK
$13B
| $162K | ﹤0.01% |
3,200
-600
| -16% | -$31.4K |
|
5733
Ceco Environmental
CECO
$3.49B
| $162K | ﹤0.01% |
18,551
-391,990
| -95% | -$2.91M |
|
5734
PUT
Ericsson
ERIC
$32.1B
| $162K | ﹤0.01% |
21,100
+11,800
| +127% | +$96.8K |
|
|
COL
5735
CALL
DELISTED
Rockwell Collins
COL
| $162K | ﹤0.01% |
1,900
-400
| -17% | -$35.7K |
|
5736
CALL
Carpenter Technology
CRS
$26.4B
| $161K | ﹤0.01% |
4,900
+2,900
| +145% | +$96.7K |
|
5737
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$5.76M
| $161K | ﹤0.01% |
521
-1,849
| -78% | -$635K |
|
|
QIHU
5738
CALL
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $161K | ﹤0.01% |
2,200
-7,100
| -76% | -$525K |
|
|
ADAP
5739
DELISTED
Adaptimmune Therapeutics
ADAP
| $160K | ﹤0.01% |
+19,574
| New | +$184K |
|
|
ERF
5740
PUT
DELISTED
Enerplus Corporation
ERF
| $160K | ﹤0.01% |
24,300
+3,700
| +18% | +$19.9K |
|
|
MXWL
5741
DELISTED
Maxwell Technologies Inc
MXWL
| $160K | ﹤0.01% |
30,242
-61,494
| -67% | -$354K |
|
|
AGEN
5742
Agenus
AGEN
$276M
| $159K | ﹤0.01% |
1,994
-527
| -21% | -$41.1K |
|
5743
Nature's Sunshine
NATR
$362M
| $159K | ﹤0.01% |
16,675
-2,434
| -13% | -$23.6K |
|
|
PETX
5744
DELISTED
Aratana Therapeutics, Inc.
PETX
| $159K | ﹤0.01% |
25,227
+10,713
| +74% | +$68.9K |
|
|
BGC
5745
PUT
DELISTED
General Cable Corporation
BGC
| $159K | ﹤0.01% |
12,500
-4,300
| -26% | -$59.4K |
|
|
NPTN
5746
DELISTED
NEOPHOTONICS CORP
NPTN
| $158K | ﹤0.01% |
16,614
-1,758
| -10% | -$19.1K |
|
|
BGC
5747
CALL
DELISTED
General Cable Corporation
BGC
| $158K | ﹤0.01% |
12,400
-5,100
| -29% | -$70.4K |
|
5748
Corvus Pharmaceuticals
CRVS
$1.1B
| $157K | ﹤0.01% |
11,010
-15,633
| -59% | -$211K |
|
|
CONN
5749
DELISTED
Conn's Inc.
CONN
| $157K | ﹤0.01% |
20,880
-60,734
| -74% | -$657K |
|
|
OSG
5750
DELISTED
Overseas Shipholding Group Inc.
OSG
| $157K | ﹤0.01% |
14,275
-49,051
| -77% | -$567K |
|
Similar funds
Goldman Sachs's Q2 2016 Portfolio in Review
As of Q2 2016, Goldman Sachs held 7,605 positions worth $306B, up 0.71% from $304B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs's Q2 2016 filing shows 546 new, 3,268 increased, 2,864 reduced and 595 closed positions. Its largest new stake was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 3,735,711 shares worth $87.8M. The largest sale was Pfizer, an estimated $2.27B.
By sector, the portfolio is most concentrated in Financials at 8.2% of assets, down from 8.6% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 3,735,711 shares worth $87.8M.
- Goldman Sachs added most to Hilton Worldwide in Q2 2016, an estimated $717M increase.
- Goldman Sachs's biggest Q2 2016 reduction was Pfizer, cutting an estimated $2.27B.
- Goldman Sachs fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $1.05B.
- Goldman Sachs's ten largest holdings make up 15% of its $306B portfolio in Q2 2016.
- Goldman Sachs opened 546 new positions and closed 595 in Q2 2016.
- Goldman Sachs's portfolio value rose 0.71% quarter-over-quarter to $306B.
Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.